West Pharmaceutical Services, Inc.'s Q2 results highlight growth driven by GLP-1 drugs and high-value products. Click for WST ...

In Q2 2025, West Pharmaceutical's revenues increased by 9.17%, suggesting that the destocking effect is vanishing. Read why ...

Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) jumped 22.9% in the afternoon session after the ...

West Pharmaceutical Services stock was soaring Thursday after the maker of injectable medicines reported better-than-expected ...

The consensus price target hints at a 25.3% upside potential for West Pharmaceutical (WST). While empirical research shows that this sought-after metric is hardly effective, an upward trend in ...

Healthcare products company West Pharmaceutical Services (NYSE:WST) reported in Q2 CY2025, with sales up 9.2% year on year to ...

The S&P 500 gained 0.1% on Thursday, July 24, 2025, notching an all-time closing high for the fourth straight day following ...

If you currently own WST and purchased prior to February 16, 2023 please contact Justin Kuehn, Esq. here , by email at ... or call (833) 672-0814. Kuehn Law pays all case costs and does not charge its ...

Shares of West Pharmaceutical Services Inc. WST slid 1.39% to $249.21 Wednesday, on what proved to be an all-around poor ...

West Pharmaceutical Services’ operating margin of 26% over the last twelve-month period is better than 18% for Catalent. This compares with 17% and 6% figures seen in 2019, before the pandemic ...

The stock price of West Pharmaceutical Services, best known for injectable pharmaceutical packaging and delivery systems, has rallied around 78% over recent weeks (vs. about a 40% gain in the S&P ...

This was the stock's second consecutive day of losses.